Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

23 trials with published results (13%)

Research Maturity

97 completed trials (54% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.3%

13 terminated out of 178 trials

Success Rate

88.2%

+1.7% vs benchmark

Late-Stage Pipeline

11%

19 trials in Phase 3/4

Results Transparency

24%

23 of 97 completed with results

Key Signals

23 with results88% success13 terminated

Data Visualizations

Phase Distribution

114Total
Not Applicable (47)
Early P 1 (3)
P 1 (21)
P 2 (24)
P 3 (13)
P 4 (6)

Trial Status

Completed97
Recruiting26
Unknown25
Terminated13
Active Not Recruiting11
Not Yet Recruiting3

Trial Success Rate

88.2%

Benchmark: 86.5%

Based on 97 completed trials

Clinical Trials (178)

Showing 20 of 20 trials
NCT00655096RecruitingPrimary

Screening for Research Participants

NCT07322302Not ApplicableRecruiting

RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)

NCT06455826Phase 1Completed

MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)

NCT06841575Not ApplicableRecruitingPrimary

Advancing Pediatric Retinal Imaging With Auto-aligned OCT

NCT04149210Phase 3Completed

FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial

NCT06891443Phase 3Recruiting

Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)

NCT04150432Not ApplicableCompletedPrimary

Correlation Between Exhaled Propofol Concentration With Plasma Concentration in Children

NCT06226545Phase 2Completed

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

NCT04127006Active Not Recruiting

Rate of Progression in EYS Related Retinal Degeneration

NCT05656027Phase 3Completed

Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia

NCT05728944Phase 3Completed

Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia

NCT02317328RecruitingPrimary

Adaptive Optics Retinal Imaging

NCT07413172Phase 2Not Yet Recruiting

Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye

NCT04663750Phase 3RecruitingPrimary

Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

NCT03846193Phase 1Terminated

FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD

NCT05414994Recruiting

Assessment of the Ocular Microbiome in Health and Disease

NCT06058637Not ApplicableCompletedPrimary

iSCREEN-study: Online Nurse-assisted Eye-screening in Home Healthcare

NCT07174687Phase 2Recruiting

SGLT2 Inhibitors in Geographic Atrophy

NCT06934577Not ApplicableRecruitingPrimary

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

NCT04428541Not ApplicableCompletedPrimary

Determination of the Validity of a Questionnaire to Assess the Visual Function of Preverbal Children With Operable Bilateral Ocular Pathologies

Scroll to load more

Research Network

Activity Timeline